Breaking News

Ajinomoto Bio-Pharma Launches Ajility

A fast track platform for drug product manufacturing.

By: Contract Pharma

Contract Pharma Staff

Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services, has launched Ajility, a flexible drug product manufacturing platform, designed to advance vaccines and therapies to market by minimizing time to production.   Aji Bio-Pharma’s Ajility platform is designed for novel therapeutics/vaccines and existing drug products with a new indication that can be used in COVID-19 trials, FDA Emergency Use Authorizations (EUA), or other programs, ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters